ELLEN KUDROW: Open Payments
NPI 1689054199 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,344 in 132 payments from 14 companies in 2025. Trend: 2023 $2,627 · 2024 $3,229 · 2025 $3,344
Food & beverage: $3,337Education: $7
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 23 | $595 |
| E.R. Squibb & Sons, L.L.C. | 13 | $471 |
| Lundbeck LLC | 19 | $446 |
| Axsome Therapeutics, Inc. | 14 | $326 |
| Alkermes, Inc. | 11 | $303 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $302 |
| ABBVIE INC. | 9 | $226 |
| Vanda Pharmaceuticals Inc. | 12 | $194 |
| Supernus Pharmaceuticals, Inc. | 6 | $125 |
| Corium, LLC | 6 | $98 |
Products named: REXULTI, COBENFY, Auvelity, ABILIFY ASIMTUFII, LYBALVI, CAPLYTA, VRAYLAR, FANAPT.
Industry payments across NY — which companies pay providers there.
